Cancers | Free Full-Text | Immune Effector Cell-Associated HLH-like Syndrome: A Review of the Literature of an Increasingly Recognized Entity
Kineret Subcutaneous: Uses, Side Effects, Interactions, Pictures, Warnings & Dosing - WebMD
Frontiers | Anakinra in Paediatric Rheumatology and Periodic Fever Clinics: Is the Higher Dose Safe?
The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis - Bami - 2020 - Pediatric Blood & Cancer - Wiley Online Library
KINERET® (anakinra) Official Website | Using KINERET for NOMID
JCM | Free Full-Text | Anakinra versus Baricitinib: Different Strategies for Patients Hospitalized with COVID-19
IJMS | Free Full-Text | Towards a Treatment for Neuroinflammation in Epilepsy: Interleukin-1 Receptor Antagonist, Anakinra, as a Potential Treatment in Intractable Epilepsy
Arthritis News: Study Finds No Treatment Benefit of Intra-Articular Anakinra in Knee Osteoarthritis
Silencing the cytokine storm: the use of intravenous anakinra in haemophagocytic lymphohistiocytosis or macrophage activation syndrome - The Lancet Rheumatology
Anakinra pharmacokinetics in children and adolescents with systemic-onset juvenile idiopathic arthritis and autoinflammatory syndromes | BMC Pharmacology and Toxicology | Full Text
2019 Clinical Guidelines Template
Intravenous anakinra for the treatment of haemophagocytic lymphohistiocytosis/macrophage activation syndrome: A systematic review - Charlesworth - European Journal of Haematology - Wiley Online Library
KINERET® (anakinra) Official HCP Website | Dosing Calculator
Development and effect of antibodies to anakinra during treatment of severe CAPS: sub-analysis of a long-term safety and efficacy study | Clinical Rheumatology
Clinical Commissioning Policy: Anakinra for Haemophagocytic Lymphohistiocytosis (HLH) for adults and children in all ages [21070
Higher-dose Anakinra Is Effective in a Case of Medically Refractory Macrophage Activation Syndrome | The Journal of Rheumatology
KINERET® (anakinra) Official HCP Website | Dosing and Administration
Anakinra reduces ventilation need, mortality in COVID-19
Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial | Nature Medicine
Reference ID: 3933625
Frontiers | Anakinra Therapy for Non-cancer Inflammatory Diseases
PulmCrit – High-dose anakinra for COVID-19: The anti-inflammatory trials begin
